Gyre Therapeutics
A majority-owned Beijing unit sells China's pirfenidone lung-fibrosis therapy while San Diego runs the antifibrotic pipeline.
$6.59
After-hours close−0.01 (−0.15%)
At close$6.60(−1.20%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.15 | — | — |
| Aug 2026 | −$0.06 | −$0.12 | −111.8% |
| May 2026 | −$0.06 | −$0.05 | +16.7% |
| Mar 2026 | $0.06 | $0.04 | −29.4% |
| Nov 2025 | $0.05 | $0.06 | +20.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | −$0.15 | — | — | $28.4M | — | — |
| Aug 7, 2026 | −$0.06 | −$0.12 | −111.8% | $26.5M | $29.1M | +9.9% |
| May 7, 2026 | −$0.06 | −$0.05 | +16.7% | $31.6M | $22.5M | −28.8% |
| Mar 12, 2026 | $0.06 | $0.04 | −29.4% | $35.4M | $37.2M | +5.0% |
| Nov 7, 2025 | $0.05 | $0.06 | +20.0% | $36.3M | $30.6M | −15.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 9, 2025 | ||||||
| Mar 17, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 26, 2024 | ||||||
| Oct 26, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 9, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 11, 2020 | ||||||
| Feb 20, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 2, 2019 | ||||||
| Mar 8, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 2, 2018 | ||||||
| May 3, 2018 | ||||||
| Mar 19, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Aug 3, 2017 | ||||||
| May 11, 2017 | ||||||
| Mar 8, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 5, 2016 | ||||||
| Mar 9, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Jul 31, 2015 | ||||||